Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_assertion type Assertion NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_head.
- NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_assertion description "[In conclusion, the reversion of insulin resistance after BPD might allow reversal of leptin resistance, restoration of leptin pulsatility, and consequent inhibition of ACC2 mRNA expression, translating to a reduced synthesis of malonyl-CoA, which, in turn, results in increased fatty acid oxidation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_provenance.
- NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_assertion evidence source_evidence_literature NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_provenance.
- NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_assertion SIO_000772 15955844 NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_provenance.
- NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_assertion wasDerivedFrom befree-20140225 NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_provenance.
- NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_assertion wasGeneratedBy ECO_0000203 NP259562.RAB_LNi-PTUwqB2IlOl52WXngb2neVuU_4OdLCCcu6OMk130_provenance.